Skip to main content
Top
Published in: Respiratory Research 1/2008

Open Access 01-12-2008 | Research

The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis

Authors: Vasanthi Govindaraju, Marie-Claire Michoud, Pasquale Ferraro, Janine Arkinson, Katherine Safka, Hector Valderrama-Carvajal, James G Martin

Published in: Respiratory Research | Issue 1/2008

Login to get access

Abstract

Background

Many cystic fibrosis (CF) patients display airway hyperresponsiveness and have symptoms of asthma such as cough, wheezing and reversible airway obstruction. Chronic airway bacterial colonization, associated with neutrophilic inflammation and high levels of interleukin-8 (IL-8) is also a common occurrence in these patients. The aim of this work was to determine the responsiveness of airway smooth muscle to IL-8 in CF patients compared to non-CF individuals.

Methods

Experiments were conducted on cultured ASM cells harvested from subjects with and without CF (control subjects). Cells from the 2nd to 5th passage were studied. Expression of the IL-8 receptors CXCR1 and CXCR2 was assessed by flow cytometry. The cell response to IL-8 was determined by measuring intracellular calcium concentration ([Ca2+]i), cell contraction, migration and proliferation.

Results

The IL-8 receptors CXCR1 and CXCR2 were expressed in both non-CF and CF ASM cells to a comparable extent. IL-8 (100 nM) induced a peak Ca2+ release that was higher in control than in CF cells: 228 ± 7 versus 198 ± 10 nM (p < 0.05). IL-8 induced contraction was greater in CF cells compared to control. Furthermore, IL-8 exposure resulted in greater phosphorylation of myosin light chain (MLC20) in CF than in control cells. In addition, MLC20 expression was also increased in CF cells. Exposure to IL-8 induced migration and proliferation of both groups of ASM cells but was not different between CF and non-CF cells.

Conclusion

ASM cells of CF patients are more contractile to IL-8 than non-CF ASM cells. This enhanced contractility may be due to an increase in the amount of contractile protein MLC20. Higher expression of MLC20 by CF cells could contribute to airway hyperresponsiveness to IL-8 in CF patients.
Literature
1.
go back to reference Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Ianuzzi MC, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066–1073.CrossRefPubMed Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Ianuzzi MC, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066–1073.CrossRefPubMed
2.
go back to reference Smith AL, Ramsey B, Redding G, Haas J: Endobronchial infection in cystic fibrosis. Acta Paediatr Scand Suppl 1989, 363:31–36.PubMed Smith AL, Ramsey B, Redding G, Haas J: Endobronchial infection in cystic fibrosis. Acta Paediatr Scand Suppl 1989, 363:31–36.PubMed
3.
go back to reference Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD: Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Brit Med J 1995, 310:1571–1572.CrossRefPubMedPubMedCentral Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD: Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Brit Med J 1995, 310:1571–1572.CrossRefPubMedPubMedCentral
4.
go back to reference Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075–1082.PubMed Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075–1082.PubMed
5.
go back to reference Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW: Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001, 32:356–366.CrossRefPubMed Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW: Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001, 32:356–366.CrossRefPubMed
6.
7.
go back to reference Mitchell I, Corey M, Woenne R, Krastins IR, Levison H: Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978, 93:744–748.CrossRefPubMed Mitchell I, Corey M, Woenne R, Krastins IR, Levison H: Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978, 93:744–748.CrossRefPubMed
8.
go back to reference Mellis CM, Levison H: Bronchial reactivity in cystic fibrosis. Pediatrics 1978, 61:446–450.PubMed Mellis CM, Levison H: Bronchial reactivity in cystic fibrosis. Pediatrics 1978, 61:446–450.PubMed
9.
go back to reference Tiddens HA, Koopman LP, Lambert RK, Elliott WM, Hop WC, Mark TW, de Boer WJ, de Jongste JC: Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs. Eur Respir J 2000, 15:735–742.CrossRefPubMed Tiddens HA, Koopman LP, Lambert RK, Elliott WM, Hop WC, Mark TW, de Boer WJ, de Jongste JC: Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs. Eur Respir J 2000, 15:735–742.CrossRefPubMed
11.
go back to reference van Haren EH, Lammers JW, Festen J, van Herwaarden CL: Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J 1992, 5:1083–1088.PubMed van Haren EH, Lammers JW, Festen J, van Herwaarden CL: Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J 1992, 5:1083–1088.PubMed
12.
go back to reference Avital A, Sanchez I, Chernick V: Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 1992, 13:34–37.CrossRefPubMed Avital A, Sanchez I, Chernick V: Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 1992, 13:34–37.CrossRefPubMed
13.
go back to reference Sagel SD, Accurso FJ: Monitoring inflammation in CF. Cytokines. Clin Rev Allergy Immunol 2002, 23:41–57.CrossRefPubMed Sagel SD, Accurso FJ: Monitoring inflammation in CF. Cytokines. Clin Rev Allergy Immunol 2002, 23:41–57.CrossRefPubMed
14.
go back to reference Nakamura H, Yoshimura K, McElvaney NG, Crystal RG: Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992, 89:1478–1484.CrossRefPubMedPubMedCentral Nakamura H, Yoshimura K, McElvaney NG, Crystal RG: Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992, 89:1478–1484.CrossRefPubMedPubMedCentral
15.
go back to reference Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1003,264(4 Pt. 1):L413-L418. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1003,264(4 Pt. 1):L413-L418.
16.
go back to reference Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E, Jacquot J: Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998, 153:921–930.CrossRefPubMedPubMedCentral Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E, Jacquot J: Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998, 153:921–930.CrossRefPubMedPubMedCentral
17.
go back to reference Konstan MW, Berger M: Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997, 24:137–142.CrossRefPubMed Konstan MW, Berger M: Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997, 24:137–142.CrossRefPubMed
18.
go back to reference Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278–1280.CrossRefPubMed Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278–1280.CrossRefPubMed
19.
go back to reference Bacon KB, Westwick J, Camp RD: Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem Biophys Res Commun 1989, 165:349–354.CrossRefPubMed Bacon KB, Westwick J, Camp RD: Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem Biophys Res Commun 1989, 165:349–354.CrossRefPubMed
20.
go back to reference Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D: Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol 1990, 144:1323–1330.PubMed Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D: Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol 1990, 144:1323–1330.PubMed
21.
go back to reference Wang JM, Walter S, Mantovani A: Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. Immunology 1990, 71:364–367.PubMedPubMedCentral Wang JM, Walter S, Mantovani A: Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. Immunology 1990, 71:364–367.PubMedPubMedCentral
22.
go back to reference Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ: Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994, 75:1–7.CrossRefPubMed Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ: Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994, 75:1–7.CrossRefPubMed
23.
go back to reference Yue TL, McKenna PJ, Gu JL, Feuerstein GZ: Interleukin-8 is chemotactic for vascular smooth muscle cells. Eur J Pharmacol 1993, 240:81–84.CrossRefPubMed Yue TL, McKenna PJ, Gu JL, Feuerstein GZ: Interleukin-8 is chemotactic for vascular smooth muscle cells. Eur J Pharmacol 1993, 240:81–84.CrossRefPubMed
24.
go back to reference Fujimura M, Myou S, Nomura M, Mizuguchi M, Matsuda T, Harada A, Mukaida N, Matsushima K, Nonomura A: Interleukin-8 inhalation directly provokes bronchoconstriction in guinea pigs. Allergy 1999, 54:386–391.CrossRefPubMed Fujimura M, Myou S, Nomura M, Mizuguchi M, Matsuda T, Harada A, Mukaida N, Matsushima K, Nonomura A: Interleukin-8 inhalation directly provokes bronchoconstriction in guinea pigs. Allergy 1999, 54:386–391.CrossRefPubMed
25.
go back to reference Govindaraju V, Michoud M-C, Al-Chalabi M, Ferraro P, Powell WS, Martin JG: Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am J Physiol Cell Physiol 2006,291(5):C957–65.CrossRefPubMed Govindaraju V, Michoud M-C, Al-Chalabi M, Ferraro P, Powell WS, Martin JG: Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am J Physiol Cell Physiol 2006,291(5):C957–65.CrossRefPubMed
26.
go back to reference Randell SH, Walstad L, Schwab UE, Grubb BR, Yankaskas JR: Isolation and culture of airway epithelial cells from chronically infected human lungs. In Vitro Cell Dev Biol Anim 2001, 37:480–489.CrossRefPubMed Randell SH, Walstad L, Schwab UE, Grubb BR, Yankaskas JR: Isolation and culture of airway epithelial cells from chronically infected human lungs. In Vitro Cell Dev Biol Anim 2001, 37:480–489.CrossRefPubMed
27.
go back to reference Govindaraju V, Martin JG, Maghni K, Ferraro P, Michoud MC: The effects of extracellular purines and pyrimidines on human airway smooth muscle cells. J Pharmacol Exp Ther 2005, 315:941–948.CrossRefPubMed Govindaraju V, Martin JG, Maghni K, Ferraro P, Michoud MC: The effects of extracellular purines and pyrimidines on human airway smooth muscle cells. J Pharmacol Exp Ther 2005, 315:941–948.CrossRefPubMed
28.
go back to reference Tao F, Chaudry S, Tolloczko B, Martin JG, Kelly SM: Modulation of smooth muscle phenotype in vitro by homologous cell substrate. Am J Physiol Cell Physiol 2003, 284:C1531-C1541.CrossRefPubMed Tao F, Chaudry S, Tolloczko B, Martin JG, Kelly SM: Modulation of smooth muscle phenotype in vitro by homologous cell substrate. Am J Physiol Cell Physiol 2003, 284:C1531-C1541.CrossRefPubMed
29.
go back to reference Reinlib L, Jefferson DJ, Marini FC, Donowitz M: Abnormal secretagogue-induced intracellular free Ca2+ regulation in cystic fibrosis nasal epithelial cells. Proc Natl Acad Sci USA 1992, 89:2955–2959.CrossRefPubMedPubMedCentral Reinlib L, Jefferson DJ, Marini FC, Donowitz M: Abnormal secretagogue-induced intracellular free Ca2+ regulation in cystic fibrosis nasal epithelial cells. Proc Natl Acad Sci USA 1992, 89:2955–2959.CrossRefPubMedPubMedCentral
30.
go back to reference Jacquot J, Maizieres M, Spilmont C, Millot JM, Sebille S, Merten M, Kammouni W, Manfait M: Intracellular free Ca2+ dynamic changes to histamine are reduced in cystic fibrosis human tracheal gland cells. FEBS Lett 1996, 386:123–127.CrossRefPubMed Jacquot J, Maizieres M, Spilmont C, Millot JM, Sebille S, Merten M, Kammouni W, Manfait M: Intracellular free Ca2+ dynamic changes to histamine are reduced in cystic fibrosis human tracheal gland cells. FEBS Lett 1996, 386:123–127.CrossRefPubMed
31.
go back to reference Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr: Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002, 26:465–474.CrossRefPubMed Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr: Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002, 26:465–474.CrossRefPubMed
32.
go back to reference Rizzo CA, Yang R, Greenfeder S, Egan RW, Pauwels RA, Hey JA: The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. J Allergy Clin Immunol 2002, 109:404–409.CrossRefPubMed Rizzo CA, Yang R, Greenfeder S, Egan RW, Pauwels RA, Hey JA: The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. J Allergy Clin Immunol 2002, 109:404–409.CrossRefPubMed
33.
go back to reference Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, Grunstein JS, Chuang S: IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002, 282:L520-L528.CrossRefPubMed Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, Grunstein JS, Chuang S: IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002, 282:L520-L528.CrossRefPubMed
34.
go back to reference Wertheim WA, Kunkel SL, Standiford TJ, Burdick MD, Becker FS, Wilke CA, Gilbert AR, Strieter RM: Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol 151(4):2166–75. 1993 Aug 15PubMed Wertheim WA, Kunkel SL, Standiford TJ, Burdick MD, Becker FS, Wilke CA, Gilbert AR, Strieter RM: Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol 151(4):2166–75. 1993 Aug 15PubMed
35.
go back to reference Mukhina S, Stepanova V, Traktouev D, Poliakov A, Beabealashvilly R, Gursky Y, Minashkin M, Shevelev A, Tkachuk V: The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem 2000, 275:16450–16458.CrossRefPubMed Mukhina S, Stepanova V, Traktouev D, Poliakov A, Beabealashvilly R, Gursky Y, Minashkin M, Shevelev A, Tkachuk V: The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem 2000, 275:16450–16458.CrossRefPubMed
36.
go back to reference Robert R, Thoreau V, Norez C, Cantereau A, Kitzis A, Mettey Y, Rogier C, Becq F: Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 2004, 279:21160–21168.CrossRefPubMed Robert R, Thoreau V, Norez C, Cantereau A, Kitzis A, Mettey Y, Rogier C, Becq F: Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 2004, 279:21160–21168.CrossRefPubMed
37.
go back to reference Michoud MC, Robert R, Hassan M, Moynihan B, Haston C, Govindaraju V, Ferraro P, Hanrahan JW, Martin JG: Role of the CFTR Channel in Human Airway Smooth Muscle. Am J Respir Cell Mol Biol, in press. 2008 Aug 28 Michoud MC, Robert R, Hassan M, Moynihan B, Haston C, Govindaraju V, Ferraro P, Hanrahan JW, Martin JG: Role of the CFTR Channel in Human Airway Smooth Muscle. Am J Respir Cell Mol Biol, in press. 2008 Aug 28
Metadata
Title
The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis
Authors
Vasanthi Govindaraju
Marie-Claire Michoud
Pasquale Ferraro
Janine Arkinson
Katherine Safka
Hector Valderrama-Carvajal
James G Martin
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2008
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-9-76

Other articles of this Issue 1/2008

Respiratory Research 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine